Description

7-(4-Bromo-1-Ethyl-1 H-Pyrazol-3-Yl)-Pyrazolo[1,5-A ]Pyrimidine-2-Carboxylic Acid is a high-value, heterocyclic organic compound serving as a critical pharmaceutical intermediate and research chemical. Its complex fused pyrazolopyrimidine structure makes it an essential building block for medicinal chemists developing novel therapeutic agents. This compound is primarily sought by R&D and production teams in the pharmaceutical and biotechnology sectors for synthesizing targeted small molecule drugs.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of active pharmaceutical ingredients (APIs) targeting various disease pathways.
• Kinase Inhibitor Development: Core scaffold for research and development of novel kinase inhibitors due to the pyrazolopyrimidine moiety.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new drug candidates.
• Chemical Biology Probes: Serves as a starting material for creating specialized probes to study biological processes and protein functions.
• Custom Synthesis: Building block for contract research and manufacturing organizations (CROs/CMOs) producing bespoke compounds for clients.
• Academic Research: Utilized in university and institutional labs for fundamental research in organic synthesis and heterocyclic chemistry.

Basic Information

Product Name	7-(4-Bromo-1-Ethyl-1 H-Pyrazol-3-Yl)-Pyrazolo[1,5-A ]Pyrimidine-2-Carboxylic Acid
CAS No.	1001500-67-9
Molecular Formula	C12H10BrN5O2
Molecular Weight	336.15 g/mol
Synonyms	7-(4-Bromo-1-ethyl-1H-pyrazol-3-yl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid; 7-(4-Bromo-1-ethylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid; 1001500-67-9; Pyrazolo[1,5-a]pyrimidine-2-carboxylic acid, 7-(4-bromo-1-ethyl-1H-pyrazol-3-yl)-; BDBM50164957; AKOS025147065; ZINC000253909991; SCHEMBL23346896
EINECS	Contact for details

Quality Control

We maintain a rigorous quality management system to ensure the integrity of our advanced intermediates. Every batch of 7-(4-Bromo-1-Ethyl-1 H-Pyrazol-3-Yl)-Pyrazolo[1,5-A ]Pyrimidine-2-Carboxylic Acid is analyzed using advanced techniques like HPLC, NMR, and LC-MS to confirm identity, purity, and the absence of critical impurities. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with each shipment to support your quality and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound may be moisture-sensitive; keep the container tightly sealed under an inert atmosphere if necessary for long-term storage.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (NMR)	Conforms
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.